TITLE

Joint Commission issues recommendations for anticoagulation therapy, safety

PUB. DATE
November 2008
SOURCE
Cardiology Today;Nov2008, Vol. 11 Issue 11, p29
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article focuses on a Sentinel Event Alert issued and a press conference held by the Joint Commission to address the safety of anticoagulation therapy. Recommendations and information about medication errors and drug-related risks posed by heparin, warfarin, and low-molecular-weight heparin comprised the alert. It outlines the factors that contribute to anticoagulation errors discussed by the commission and reports that the commission recommended the development and implementation of risk reduction strategies.
ACCESSION #
35639358

 

Related Articles

  • Improving Heparin Safety: A Multidisciplinary Invited Conference. Peterson, Carl; Ham, Charles W.; Vanderveen, Tim // Hospital Pharmacy;Jun2008, Vol. 43 Issue 6, p491 

    Heparin is widely used in a variety of settings for prevention and treatment of thromboembolic events. Data from a number of sources indicate that it is also one of the drugs most frequently associated with adverse events and medication errors, many of which are serious. National media attention...

  • Monitoring effects of oral anticoagulants during treatment with heparin.  // British Medical Journal (Clinical Research Edition);1/21/1984, Vol. 288 Issue 6412, p191 

    Examines the effect of heparin on the corrected ration in Great Britain. Variations in sensitivity to warfarin; Recommendation for treatment with warfarin; Methods of collecting blood samples from patients receiving both heparin and warfarin.

  • Prescription drugs: uses and effects: Anticoagulants. Lake, Richard; Jordan, Sue // Nursing Standard;1/19/2005, Vol. 19 Issue 19, p113 

    The article focuses on anticoagulants, which reduce the formation of new blood clots and the extension of existing blood clots. It offers information on when the drugs should be used and their administration. Contraindications, interactions, and managing the adverse effects of anticoagulants...

  • Enoxaparin sodium/heparin/warfarin.  // Reactions Weekly;1/10/2009, Issue 1234, p18 

    The article discusses the case of a 64-year-old woman with pulmonary emboli who experienced skin necrosis and thrombocytopenia during treatment with anticoagulation therapy with heparin then enoxaparin sodium and warfarin. It references a study by O. I. Abdel-Wahab et al, published in a 2008...

  • 'More side-effects' with dabigatran than warfarin.  // Pulse;5/23/2012, Vol. 72 Issue 19, p4 

    The article reports on the new analysis on anticoagulant dabigatran which was found out to have more complications and side-effects than warfarin.

  • Oxcarbazepine/warfarin interaction.  // Reactions Weekly;12/5/2009, Issue 1281, p25 

    The article describes the case of a boy who developed warfarin resistance while receiving treatment with oxcarbazepine. He was referred to a clinic for a low international normalized ratio (INR) despite receiving warfarin therapy. Oxcarbazepine was stopped but he was still admitted since his INR...

  • Warfarin.  // Reactions Weekly;11/15/2008, Issue 1228, p34 

    The article describes the case of an 85-year-old woman who developed a massive retropharyngeal haematoma while receiving warfarin as an anticoagulant in atrial fibrillation. After receiving warfarin, he collapsed and experienced difficulty breathing. She was given vitamin K and prothrombin...

  • RE-LY trial: both warfarin and dabigatran etexilate reduce GFR.  // Reactions Weekly;Jul2015, Vol. 1558 Issue 1, p11 

    The article reports that according to findings from the multinational RE-LY trial, long-term treatment with warfarin or dabigatran etexilate reduces the glomerular filtration rate.

  • Heparin.  // Reactions Weekly;1/16/2010, Issue 1284, p26 

    The article presents the case of a 59-year-old man who developed thrombocytopenia while undergoing heparin treatment for anticoagulation. Five days following his first intake of heparin, the patient's platelet count dropped dramatically. Heparin was discontinued and bivalirudin was used as an...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics